[Retracted] Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum

Table 1

Comparing demographic data among two groups.

Variable	Test group ()	Control group ()
Age (year)			0.464
BMI (kg/m^2)			0.370
Disease duration (month)			0.211
Gender
Male	28 (53.8)	33 (55.0)	0.903
Female	24 (46.2)	27 (45.0)